Category Archives: Events

Clayton Christensen on the Future of Pharma

By Ben Comer | Published: May 11, 2012
A keynote speaker at the 9thAnnual SaS Health Care & Life Sciences Executive Conference on May 10, ‘disruptive’ author of The Innovator’s Dilemma and Harvard business professor Clayton Christensen sat down with PharmExec to discuss the future of the pharmaceutical industry, and what Mitt Romney could bring to the White House.
Also posted in Biotech, FDA, IP, People, R&D, Regulatory, Safety, Technology, Uncategorized, healthcare, leadership | Tagged , , , , , , , , , , , , | 1 Comment

Strategic Patient Adherence Awards: This Year's Winner…

By William Looney | Published: May 11, 2012
CBI conference highlights three turnaround strategies to plug the gaps in patient adherence. New insights into customer behavior fostered by the revolution in information technology are finally being applied to the age-old quandary of why most patients stop taking prescribed medications after a few months of therapy. This was a key conclusion of last month’s [...]
Also posted in patient compliance | Tagged , | 1 Comment

Heady Ideas for Digital Health Marketing

By Ben Comer | Published: May 1, 2012
If you really want to know what’s on a patient’s mind, it’s best to skip the small talk and go straight to the brain waves, as demonstrated by Neuro Insight CEO Pranav Yadav in the lead-off presentation yesterday at Chandler Chicco’s Pioneers in Digital Health conference.
Also posted in Advertising, Agency Insight, E-Media, Marketing, Patient Communication, Sales, Strategy, Technology, leadership, social media | Tagged , , , , , , , | Leave a comment

The Digital World is Changing Fast. Can You Keep Up?

By Guest Blogger | Published: April 26, 2012
by Ritesh Patel, global head of digital at Chandler Chicco Companies I’ve been doing this digital thing for some time now. I’ve been part of and witnessed many changes in our digital world. However, I have never seen such a swift pace of change and digital adoption of late. It’s stunning how quickly things spread and [...]
Also posted in Agency Insight, Guest Blog, healthcare | Tagged , , , | Leave a comment

Dare to Compare: Genzyme Bets on MS

By Ben Comer | Published: April 25, 2012
Riding positive data on a late-phase multiple sclerosis drug, Genzyme execs talked up the company’s willingness to go head-to-head against Rebif, EMD Serono and Pfizer’s blockbuster beta interferon. Genzyme execs didn’t go so far as to reiterate former CEO Henri Termeer’s 2010 prediction of $3 billion plus in potential sales for Lemtrada (alemtuzumab), but [...]
Also posted in Biotech, FDA, Global, IP, R&D, Regulatory, Safety, Sales, Strategy, Technology | Tagged , , , | 1 Comment